A Comparison of neoadjuvant chemotherapy and concurrent chemoradiotherapy for for FIGO 2018 stage IB3/IIA2 Cervical squamous cell carcinoma: Long-term efficacy and safety in a resource-limited setting
In resource-limited settings, for patients with FIGO 2018 stage IB3/IIA2 cervical squamous cell carcinoma, 3DCRT-based CCRT offers superior disease-free survival and reduced recurrence rates compared to NCRS, despite increased early complication rates.
Authors
- Chuangzhen Chen (ORCID: https://orcid.org/0000-0002-2342-8099)
- Y. Ji
- Jianzhou Chen (ORCID: https://orcid.org/0000-0002-3645-3904)
- Renxian Xie (ORCID: https://orcid.org/0009-0007-3150-4382)
- Karen L. Xie (ORCID: https://orcid.org/0000-0003-1373-2975)
- Xiaoluan Lin
Institutions
- Shantou University (CN)
- Cancer Hospital of Shantou University Medical College (CN)
- Shantou University Medical College (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1371/journal.pone.0319405
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06